top of page

Moonwalk Biosciences raises $57 million today to pursue epigenome engineering

  • blonca9
  • Jan 4, 2024
  • 1 min read

Co-Founder and CEO Alex Aravanis describes how epigenetic engineering could have advantages over gene editing and why he thinks Moonwalk's 'complete view' of the epigenome could give it an edge in this space.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC_IB_Stacked_logo.png

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

bottom of page